Journal
ADVANCED PHARMACEUTICAL BULLETIN
Volume 11, Issue 1, Pages 39-55Publisher
TABRIZ UNIV MEDICAL SCIENCES & HEALTH SERVICES
DOI: 10.34172/apb.2021.005
Keywords
PMP; Platelet; Microparticle; Cancer
Categories
Ask authors/readers for more resources
Platelet-derived microparticles (PMPs) are micrometer-scale extracellular vesicles released by platelets upon activation, and their potential roles and effects in cancer progression have been conflictingly implicated. Understanding the intricate interplay between PMPs and cancer is crucial for future considerations of PMPs usage in cancer targeted therapy.
Platelet-derived microparticles (PMPs) are a group of micrometer-scale extracellular vesicles released by platelets upon activation that are responsible for the majority of microvesicles found in plasma. PMPs' physiological properties and functions have long been investigated by researchers. In this regard, a noticeable area of studies has been devoted to evaluating the potential roles and effects of PMPs on cancer progression. Clinical and experimental evidence conflictingly implicates supportive and suppressive functions for PMPs regarding cancer. Many of these functions could be deemed as a cornerstone for future considerations of PMPs usage in cancer targeted therapy. This review discusses what is currently known about PMPs and provides insights for new and possible research directions for further grasping the intricate interplay between PMPs and cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available